Global issues related to the impact of untreated attention-deficit/ hyperactivity disorder from childhood to young adulthood

Postgraduate Medicine

Volumn 120, Issue 3, 2008, Pages 48-59

  Barkley, Russell A ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NONE   (United States)

Author keywords

ADHD; Atomoxetine; Attention deficit hyperactivity disorder; CONCERTA ; Outcome assessment; Stimulant medication; Strattera

Indexed keywords

AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE; OROS; PLACEBO; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT;

ACADEMIC ACHIEVEMENT; ACCIDENT; ADULTHOOD; ARTICLE; ATTENTION DEFICIT DISORDER; CAR DRIVING; CAREGIVER; CHILDHOOD; CHRONIC DISEASE; COST OF ILLNESS; DELAYED DIAGNOSIS; DRIVING ABILITY; DRUG FORMULATION; FAMILY ASSESSMENT; FAMILY RELATION; FAMILY STRESS; HEALTH CARE COST; HUMAN; LIFESPAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEER PRESSURE; QUALITY OF LIFE; SOCIAL ASPECT; SOCIAL STATUS; SUBSTANCE ABUSE; ADOLESCENT; ADULT; CHILD; EDUCATIONAL STATUS; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL BEHAVIOR;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COST OF ILLNESS; EDUCATIONAL STATUS; FAMILY RELATIONS; HUMANS; QUALITY OF LIFE; SOCIAL BEHAVIOR;

EID: 56149085994     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.09.1907     Document Type: Article

References (91)

1. American Academy of Pediatrics. Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108(4):1033-1044.
2. Wilens TE, Biederman J, Spencer TJ. Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med. 2002;53:113-131. (Pubitemid 34177874)
3. Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005;90(suppl 1):i2-i7. (Pubitemid 40187993)
4. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria; I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990;29(4):546-557. (Pubitemid 20235340)
5. Murphy KR, Barkley RA. Adults with ADHD: comorbidity and adaptive functioning. Compr Psychiatry. 1996;37(6):393-401.
6. Heiligenstein E, Conyers LM, Berns AR, Miller MA. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students. J Am Coll Health. 1998;46(4):185-188. Erratum in J Am Coll Health. 1998;46(5):213.
7. Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry. 2003;11(suppl 64):9-13. (Pubitemid 37169643)
8. Kessler RC, Adler L, Ames M, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47(6):565-572. (Pubitemid 40847440)
9. Barkley RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says. New York, NY: Guilford; 2008.
10. Hoza B, Mrug S, Gerdes AC, et al. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J Consult Clin Psychol. 2005;73(3):411-423. (Pubitemid 40885091)
11. Currie J, Stabile M. Child Mental Health and Human Capital Accumulation: The Case of ADHD. Cambridge, MA: National Bureau of Economic Research; 2004. Working Paper 10435.
12. Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, Secnik K. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health. 2004;35(4):346.e1-e9. (Pubitemid 39265373)
13. Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching DP. Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord. 2004;7(3):163-173. (Pubitemid 38490895)
14. Antshel KM, Barkley R. Psychosocial interventions in attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2008;17(2):421-437.
15. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population survey. J Dev Behav Pediatr. 2006;27(1):1-10. (Pubitemid 44315107)
16. Cox DJ, Merkel L, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder. J Nerv Ment Dis. 2000;188:230-234.
17. Pelham WE, Gnagy EM, Burrows-Maclean L, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001;107(6):E105.
18. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2):e20.
19. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922-928. (Pubitemid 32667075)
20. Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs. 2003;17(2):117-131.
21. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder; impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816-818. (Pubitemid 30249663)
22. Greene RW, Biederman J, Faraone SV, Sienna M, Garcia-Jetton J. Adolescent outcome of boys with attention-deficit/hyperactivity disorder and social disability: results from a 4-year longitudinal follow-up study. J Consult Clin Psychol. 1997;65(5):758-767. (Pubitemid 27439068)
23. Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up: I. Psychiatric status. Arch Gen Psychiatry. 1985;42(10):937-947. (Pubitemid 15245086)
24. Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36(2):167-179. (Pubitemid 43126141)
25. Fergusson DM, Lynskey MT, Horwood LJ. Attention difficulties in middle childhood and psychosocial outcomes in young adulthood. J Child Psychol Psychiatry. 1997;38(6):633-644. (Pubitemid 27437729)
26. Hinshaw SP, Owens EB, Sami N, Fargeon S. Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: evidence for continuing cross-domain impairment. J Consult Clin Psychol. 2006;74(3):489-499. (Pubitemid 44128229)
27. Barkley RA, Anastopoulos AD, Guevremont DG, Flelcher KF. Adolescents with attention deficit hyperactivity disorder: patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry. 1991;30(5):752-761.
28. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004;114(5):e541-e547. (Pubitemid 41655750)
29. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1222-1227. (Pubitemid 27381278)
30. Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed. 2006;8(3):12. (Pubitemid 44144853)
31. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford; 2006.
32. Johnston C, Mash EJ. Families of children with attention-deficit/ hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev. 2001;4(3):183-207. (Pubitemid 33610771)
33. Podolski CL, Nigg JT. Parent stress and coping in relation to child ADHD severity and associated child disruptive behavior problems. J Clin Child Psychol. 2001;30(4):503-513. (Pubitemid 33658639)
34. Pelham WE Jr, Lang AR. Can your children drive you to drink? Stress and parenting in adults interacting with children with ADHD. Alcohol Res Health. 1999;23(4):292-298.
35. Faraone SV, Biederman J, Chen WJ, Milberger S, Warburton R, Tsuang MT. Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol. 1995;104(2):334-345.
36. Kendall J. Sibling accounts of attention deficit hyperactivity disorder. Fam Process. 1999;38(1):117-136.
37. Minde K, Eakin L, Hechtman L, et al. The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry. 2003;44(4):637-646. (Pubitemid 36943993)
38. Eakin L, Minde K, Hechtman L, et al. The marital and family functioning of adults with ADHD and their spouses. J Atten Disord. 2004;8(1):1-10. (Pubitemid 39407101)
39. Leibson CL, Katusie SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001;285(1):60-66. (Pubitemid 32042717)
40. Brook U, Boaz M. Adolescents with attention deficit and hyperactivity disorder/learning disability and their proneness to accidents. Indian J Pediatr. 2006;73(4):299-303. (Pubitemid 44326186)
41. Clancy TA, Rucklidge JJ, Owen D. Road-crossing safety in virtual reality: a comparison of adolescents with and without ADHD. J Am Acad Child Adolesc Psychiatry. 2006;35(2):203-215.
42. Barkley RA, Guevremont DC, Anastopoulos AD, DuPaul GJ, Shelton TL. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics. 1993,92(2):212-218. (Pubitemid 23226834)
43. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics. 1996;98(6 pt 1):1089-1095. (Pubitemid 26399271)
44. Barkley RA, Murphy KR, DuPaul GJ, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc. 2002;8:655-672. (Pubitemid 34928352)
45. Nada-Raja S, Langley JD, McGee R, Williams SM, Begg DJ, Reeder AI. Inattentive and hyperactive behaviors and driving offenses in adolescence. J Am Acad Child Adolesc Psychiatry. 1997;36(4):515-522. (Pubitemid 27149189)
46. Richards TL, Deffenbacher JL. Rosén LA. Driving angct and other driving-related behaviors in high and low ADHD symptom college students. J Atten Disord. 2002;6(1):25-38.
47. Richards TL, Deffenbacher JL, Rosén LA, Barkley RA, Rodricks T. Driving anger and driving behavior in adults with ADHD. J Atten Disord. 2006;10(1):54-64.
48. Fried R, Petty CR, Surman CB, et al. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry. 2006;67(4):567-574. (Pubitemid 43764233)
49. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113-128. (Pubitemid 46321543)
50. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry. 1998;44(4):269-273. (Pubitemid 28389712)
51. Bukstein OG. Disruptive behavior disorders and substance use disorders in adolescents. J Psychoactive Drugs. 2000;32(1):67-79. (Pubitemid 30243517)
52. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry. 1998;155(4):493-498. (Pubitemid 28207444)
53. August GJ, Winters KC, Realmuto GM, Fahnhorst T, Botzet A, Lee S. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006;45(7):824-832. (Pubitemid 43932909)
54. Ernst M, Luckenbaugh DA, Moolchan ET, et al. Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/ hyperactivity disorder. Pediatrics. 2006;117(6):2030-2039. (Pubitemid 46071248)
55. Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. J Am Board Fam Pract. 2004;17(4):235-239.
56. Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Relative benefits of stimulant therapy with OROS® methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Pediatrics. 2006;118(3):e704-e710. (Pubitemid 46089997)
57. Barber S, Grubbs L, Cottrell B. Self-perception in children with attention deficit/hyperactivity disorder. J Pediatr Nurs. 2005;20(4):235-245. (Pubitemid 41001358)
58. Edbom T, Lichtenstein P, Granlund M, Larsson JO. Long-term relationships between symptoms of attention deficit hyperactivity disorder and self-esteem in a prospective longitudinal study of twins.Acta Paediatr. 2006;95(6):650-657. (Pubitemid 43879557)
59. Frankel F, Cantwell DP, Myatt R, Feinberg DT. Do stimulants improve self-esteem in children with ADHD and peer problems? J Child Adolesc Psychopharmacol. 1999;9(3):185-194. (Pubitemid 29463590)
60. Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder. Pediatr Drugs. 2003;5(12):787-794.
61. Zhang HF, Cooper KM. OROS® MPH significantly improves family relations in adolescents. Poster presented at the 18th Annual US Psychiatric and Mental Health Congress; November 2005; Las Vegas, NV.
62. Connor DF, Edwards G, Fletcher KE, Baird J, Barkley RA, Steingard RJ. Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42(2):193-200. (Pubitemid 39610599)
63. Goodman DW, Ginsberg L, Weisler RH, Cutler AJ, Hodgkins P. An interim analysis of the Quality of Life, Effectiveness. Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005;10(12):26-34. (Pubitemid 43010495)
64. Wigal SB, McGough JJ, McCracken JT, et al. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit-hyperactivity disorder. J Atten Disord. 2005;9(1):275-289. (Pubitemid 41551759)
65. Faraone SV, Wigal SB, Hodgkins P. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR®) and atomoxetine (Strattera®) in school-aged children with ADHD. J Atten Disord. 2007;11(1):74-82.
66. Danforth JS, Anderson LP, Barkley RA, Stokes TF. Observations of parent-child interactions with hyperactive children: Research and clinical implications. Clin Psychol Rev. 1991;11:703-727.
67. Zhang HF, Cooper KM. Physician-rated and patient-reported ADHD symptom improvement with OROS® MPH treatment in adolescents. Poster presented at the 18th Annual US Psychiatric and Mental Health Congress;November 2005;Las Vegas, NV.
68. Leibson CL, Barbaresi WJ, Ransom J, et al. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment. Ambul Pediatr. 2006;6(1):45-53. (Pubitemid 43298514)
69. Barkley RA, Murphy KR, O'Connell T, Connor DF. Effects of two doses of methylphenidale on simulator driving performance in adults with attention deficit hyperactivity disorder. J Safety Res. 2005;36(2):121-131.
70. Biederman J. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. J Clin Psychiatry, 2003;64(suppl 11):3-8. (Pubitemid 37169642)
71. DuPont RL, Bensinger PB. Abuse-resistant drug delivery. Psychiatr Ann. 2005;35(8):253-256. (Pubitemid 40460116)
72. Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobson SJ. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Am Acad Child Adolesc Psychiatry. 2005;15(5):764-776. (Pubitemid 41567148)
73. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study. Am J Psychiatry. May 2008;165(5):553-555.
74. Robison LM, Skaer TL, Selar DA, Galin RS. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs. 2002;16(2):129-137. (Pubitemid 34155209)
75. Stevens J, Harman JS, Kelleher KJ. Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2004;25(5):318-325. (Pubitemid 39517389)
76. Sankaranarayanan J, Puumala SE, Kratochvil CJ. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003. Curr Med Res Opin. 2006;22(8):1475-1491.
77. Perwien A, Hall J, Swensen A, Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/ hyperactivity disorder. J Manag Cure Pharm. 2004;10(2):122-129.
78. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296- 1310. (Pubitemid 32804122)
79. Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159(6):572-578. (Pubitemid 40973481)
80. Lage M, Hwang P. Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment. J Child Adolesc Psychopharmacol. 2004;14:575-581.
81. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559-567. (Pubitemid 38812367)
82. Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention-deficit- hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005;21(2):195-206. (Pubitemid 40469896)
83. Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry. 2003;42(12):1415-1423. (Pubitemid 39585971)
84. Matza LS, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost Eff Resour Alloc. 2005;3:5. (Pubitemid 41613900)
85. Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics. 2005;23(1):93-102. (Pubitemid 40194012)
86. Leibson CL, Long KH. Economic implications of attention-deficit hyperactivity disorder for healthcare systems. Pharmacoeconomics. 2003;21(17):1239-1262. (Pubitemid 37523754)
87. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the Medical Expenditure Panel Survey. Arch Pediatr Adolesc Med. 2002;156(5):504-511. (Pubitemid 34492585)
88. Burd L, Klug MG, Coumbe MJ, Kerbeshian J. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care. J Child Neurol. 2003;18:555-561. (Pubitemid 37098632)
89. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(1):71-78. (Pubitemid 32592007)
90. Jensen PS, Garcia JA, Glied S, et al. Cost-effectiveness of ADHD treatments: findings from the Multimodal Treatment Study of Children with ADHD. Am J Psychiatry, 2005;162(9):1628-1636. (Pubitemid 41318231)
91. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073-1086.